• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

建立、验证和评估伴有微血管侵犯的 R0 切除术后肝癌患者早期复发的预测模型。

Establishment, validation and evaluation of predictive model for early relapse after R0 resection in hepatocellular carcinoma patients with microvascular invasion.

机构信息

Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), No. 17 Panjiayuannanli, Chaoyang District, Beijing, 100021, China.

出版信息

J Transl Med. 2021 Jul 6;19(1):293. doi: 10.1186/s12967-021-02940-0.

DOI:10.1186/s12967-021-02940-0
PMID:34229698
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8261942/
Abstract

BACKGROUNDS

This is the first study to build and evaluate a predictive model for early relapse after R0 resection in hepatocellular carcinoma (HCC) patients with microvascular invasion (MVI).

METHODS

The consecutive HCC patients with MVI who underwent hepatectomy in Cancer Hospital of Chinese Academy of Medical Science from Jan 2014 to June 2019 were retrospectively enrolled and randomly allocated into a derivation (N = 286) and validation cohort (N = 120) in a ratio of 7:3. Cox regression and Logistic regression analyses were performed and a predictive model for postoperative early-relapse were developed.

RESULTS

A total of 406 HCC patients with MVI were included in our work. Preoperative blood alpha-fetoprotein (AFP) level, hepatitis B e antigen (HBeAg) status, MVI classification, largest tumor diameter, the status of serosal invasion, number of tumors, and the status of satellite nodules were incorporated to construct a model. The concordance index (C-index) was 0.737 and 0.736 in the derivation and validation cohort, respectively. The calibration curves showed a good agreement between actual observation and nomogram prediction. The C-index of the nomogram was obviously higher than those of the two traditional HCC staging systems.

CONCLUSION

We have developed and validated a prediction model for postoperative early-relapse in HCC patient with MVI after R0 resection.

摘要

背景

这是第一项构建和评估伴有微血管侵犯(MVI)的肝细胞癌(HCC)患者 R0 切除术后早期复发预测模型的研究。

方法

回顾性纳入 2014 年 1 月至 2019 年 6 月在中国医学科学院肿瘤医院接受肝切除术的连续 HCC 伴 MVI 患者,并按照 7:3 的比例随机分配到推导队列(N=286)和验证队列(N=120)。进行 Cox 回归和 Logistic 回归分析,并建立术后早期复发的预测模型。

结果

本研究共纳入 406 例伴有 MVI 的 HCC 患者。术前血液甲胎蛋白(AFP)水平、乙型肝炎 e 抗原(HBeAg)状态、MVI 分级、最大肿瘤直径、浆膜侵犯状态、肿瘤数量和卫星结节状态被纳入模型构建。推导和验证队列的一致性指数(C-index)分别为 0.737 和 0.736。校准曲线显示实际观察值与列线图预测值之间具有良好的一致性。该列线图的 C-index 明显高于两个传统的 HCC 分期系统。

结论

我们已经开发并验证了一种用于伴有 MVI 的 HCC 患者 R0 切除术后术后早期复发的预测模型。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a4b/8261942/7a912e4cfed3/12967_2021_2940_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a4b/8261942/a931cc0f61b8/12967_2021_2940_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a4b/8261942/7a912e4cfed3/12967_2021_2940_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a4b/8261942/a931cc0f61b8/12967_2021_2940_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a4b/8261942/7a912e4cfed3/12967_2021_2940_Fig2_HTML.jpg

相似文献

1
Establishment, validation and evaluation of predictive model for early relapse after R0 resection in hepatocellular carcinoma patients with microvascular invasion.建立、验证和评估伴有微血管侵犯的 R0 切除术后肝癌患者早期复发的预测模型。
J Transl Med. 2021 Jul 6;19(1):293. doi: 10.1186/s12967-021-02940-0.
2
Nomogram for Preoperative Estimation of Microvascular Invasion Risk in Hepatitis B Virus-Related Hepatocellular Carcinoma Within the Milan Criteria.米兰标准范围内乙型肝炎病毒相关性肝细胞癌微血管侵犯风险的术前预测列线图。
JAMA Surg. 2016 Apr;151(4):356-63. doi: 10.1001/jamasurg.2015.4257.
3
An Eastern Hepatobiliary Surgery Hospital Microvascular Invasion Scoring System in Predicting Prognosis of Patients with Hepatocellular Carcinoma and Microvascular Invasion After R0 Liver Resection: A Large-Scale, Multicenter Study.东方肝胆外科医院微血管侵犯评分系统预测 R0 肝切除术后肝细胞癌伴微血管侵犯患者的预后:一项大样本、多中心研究。
Oncologist. 2019 Dec;24(12):e1476-e1488. doi: 10.1634/theoncologist.2018-0868. Epub 2019 May 28.
4
Novel microvascular invasion-based prognostic nomograms to predict survival outcomes in patients after R0 resection for hepatocellular carcinoma.基于微血管侵犯的新型预后列线图预测肝细胞癌R0切除术后患者的生存结局
J Cancer Res Clin Oncol. 2017 Feb;143(2):293-303. doi: 10.1007/s00432-016-2286-1. Epub 2016 Oct 14.
5
Development and validation of a prediction model for microvascular invasion in hepatocellular carcinoma.肝细胞癌微血管侵犯预测模型的建立与验证。
World J Gastroenterol. 2020 Apr 14;26(14):1647-1659. doi: 10.3748/wjg.v26.i14.1647.
6
Microvascular invasion and positive HB e antigen are associated with poorer survival after hepatectomy of early hepatocellular carcinoma: A retrospective cohort study.微血管侵犯和乙肝e抗原阳性与早期肝细胞癌肝切除术后较差的生存率相关:一项回顾性队列研究。
Clin Res Hepatol Gastroenterol. 2018 Sep;42(4):330-338. doi: 10.1016/j.clinre.2018.02.003. Epub 2018 Mar 16.
7
A novel classification in predicting prognosis and guiding postoperative management after R0 liver resection for patients with hepatocellular carcinoma and microvascular invasion.一种新的分类方法,用于预测肝细胞癌伴微血管侵犯患者 R0 肝切除术后的预后并指导术后管理。
Eur J Surg Oncol. 2022 Jun;48(6):1348-1355. doi: 10.1016/j.ejso.2021.12.466. Epub 2021 Dec 29.
8
Preoperative radiomics nomogram for microvascular invasion prediction in hepatocellular carcinoma using contrast-enhanced CT.基于增强 CT 的术前影像组学Nomogram 模型预测肝细胞癌微血管侵犯
Eur Radiol. 2019 Jul;29(7):3595-3605. doi: 10.1007/s00330-018-5985-y. Epub 2019 Feb 15.
9
Clinical Nomogram Model for Pre-Operative Prediction of Microvascular Invasion of Hepatocellular Carcinoma before Hepatectomy.临床列线图模型预测肝癌切除术前行微血管侵犯的术前预测。
Medicina (Kaunas). 2024 Aug 28;60(9):1410. doi: 10.3390/medicina60091410.
10
Association of Preoperative Antiviral Treatment With Incidences of Microvascular Invasion and Early Tumor Recurrence in Hepatitis B Virus-Related Hepatocellular Carcinoma.术前抗病毒治疗与乙型肝炎病毒相关性肝细胞癌微血管侵犯和早期肿瘤复发的关系。
JAMA Surg. 2018 Oct 1;153(10):e182721. doi: 10.1001/jamasurg.2018.2721. Epub 2018 Oct 17.

引用本文的文献

1
Adjuvant Hepatic Arterial Infusion Chemotherapy Versus Transarterial Chemoembolization for Preventing Early Recurrence After Surgical Resection in Hepatocellular Carcinoma.辅助性肝动脉灌注化疗与经动脉化疗栓塞术预防肝细胞癌手术切除后早期复发的比较
J Hepatocell Carcinoma. 2025 Jul 16;12:1425-1439. doi: 10.2147/JHC.S510814. eCollection 2025.
2
Radiomics analysis based on dynamic contrast-enhanced MRI for predicting early recurrence after hepatectomy in hepatocellular carcinoma patients.基于动态对比增强磁共振成像的影像组学分析预测肝细胞癌患者肝切除术后早期复发
Sci Rep. 2025 Jul 1;15(1):22240. doi: 10.1038/s41598-025-02291-6.
3

本文引用的文献

1
Postoperative adjuvant treatment strategy for hepatocellular carcinoma with microvascular invasion: a non-randomized interventional clinical study.肝细胞癌合并微血管侵犯患者的术后辅助治疗策略:一项非随机介入性临床研究。
BMC Cancer. 2020 Jul 1;20(1):614. doi: 10.1186/s12885-020-07087-7.
2
Repeat hepatectomy for patients with early and late recurrence of hepatocellular carcinoma: A multicenter propensity score matching analysis.再次肝切除术治疗肝细胞癌早期和晚期复发患者:多中心倾向评分匹配分析。
Surgery. 2021 Apr;169(4):911-920. doi: 10.1016/j.surg.2019.11.005. Epub 2019 Dec 23.
3
Defining and predicting early recurrence after liver resection of hepatocellular carcinoma: a multi-institutional study.
Chinese expert consensus on the diagnosis and treatment of hepatocellular carcinoma with microvascular invasion (2024 edition).
肝细胞癌微血管侵犯诊断与治疗中国专家共识(2024年版)
Hepatobiliary Surg Nutr. 2025 Apr 1;14(2):246-266. doi: 10.21037/hbsn-24-359. Epub 2024 Dec 30.
4
Patterns and outcomes of early and late recurrence after hepatectomy for hepatocellular carcinoma with microvascular invasion: a multicenter study in China.伴有微血管侵犯的肝细胞癌肝切除术后早期和晚期复发的模式及结局:一项中国的多中心研究
Hepatol Int. 2025 Mar 10. doi: 10.1007/s12072-025-10802-w.
5
Consensus on the tertiary prevention of primary liver cancer.原发性肝癌三级预防共识。
Hepatol Int. 2023 Oct;17(5):1057-1071. doi: 10.1007/s12072-023-10549-2. Epub 2023 Jun 27.
6
Construction of a predictive nomogram and bioinformatic investigation of the potential mechanism of postoperative early recurrence of hepatocellular carcinoma meeting the Milan criteria.符合米兰标准的肝细胞癌术后早期复发预测列线图的构建及潜在机制的生物信息学研究
Ann Transl Med. 2022 Aug;10(16):866. doi: 10.21037/atm-22-3390.
7
A Promising Preoperative Prediction Model for Microvascular Invasion in Hepatocellular Carcinoma Based on an Extreme Gradient Boosting Algorithm.基于极端梯度提升算法的肝细胞癌微血管侵犯术前预测模型
Front Oncol. 2022 Mar 4;12:852736. doi: 10.3389/fonc.2022.852736. eCollection 2022.
8
The Dynamic Changes of AFP From Baseline to Recurrence as an Excellent Prognostic Factor of Hepatocellular Carcinoma After Locoregional Therapy: A 5-Year Prospective Cohort Study.从基线到复发时甲胎蛋白的动态变化作为局部区域治疗后肝细胞癌的一个良好预后因素:一项5年前瞻性队列研究。
Front Oncol. 2021 Dec 16;11:756363. doi: 10.3389/fonc.2021.756363. eCollection 2021.
9
Commentary: A preoperative model for predicting microvascular invasion and assisting in prognostic stratification in liver transplantation for HCC regarding empirical criteria.评论:关于经验标准的预测微血管侵犯及辅助肝癌肝移植预后分层的术前模型
Transl Oncol. 2021 Dec;14(12):101234. doi: 10.1016/j.tranon.2021.101234. Epub 2021 Oct 6.
定义和预测肝癌肝切除术后早期复发:多机构研究。
HPB (Oxford). 2020 May;22(5):677-689. doi: 10.1016/j.hpb.2019.09.006. Epub 2019 Oct 10.
4
Combined preoperative albumin-bilirubin (ALBI) and serum γ-glutamyl transpeptidase (GGT) predicts the outcome of hepatocellular carcinoma patients following hepatic resection.术前联合白蛋白-胆红素(ALBI)和血清γ-谷氨酰转肽酶(GGT)可预测肝细胞癌患者肝切除术后的预后。
J Cancer. 2019 Aug 27;10(20):4836-4845. doi: 10.7150/jca.33877. eCollection 2019.
5
Biology and significance of alpha-fetoprotein in hepatocellular carcinoma.甲胎蛋白在肝细胞癌中的生物学特性及意义。
Liver Int. 2019 Dec;39(12):2214-2229. doi: 10.1111/liv.14223. Epub 2019 Sep 11.
6
Adjuvant transarterial chemoembolization improves survival outcomes in hepatocellular carcinoma with microvascular invasion: A systematic review and meta-analysis.辅助经动脉化疗栓塞可改善伴微血管侵犯的肝细胞癌患者的生存结局:系统评价和荟萃分析。
Eur J Surg Oncol. 2019 Nov;45(11):2188-2196. doi: 10.1016/j.ejso.2019.06.031. Epub 2019 Jun 25.
7
An Eastern Hepatobiliary Surgery Hospital Microvascular Invasion Scoring System in Predicting Prognosis of Patients with Hepatocellular Carcinoma and Microvascular Invasion After R0 Liver Resection: A Large-Scale, Multicenter Study.东方肝胆外科医院微血管侵犯评分系统预测 R0 肝切除术后肝细胞癌伴微血管侵犯患者的预后:一项大样本、多中心研究。
Oncologist. 2019 Dec;24(12):e1476-e1488. doi: 10.1634/theoncologist.2018-0868. Epub 2019 May 28.
8
Surgery for Recurrent Hepatocellular Carcinoma: Achieving Long-term Survival.复发性肝细胞癌的外科治疗:实现长期生存。
Ann Surg. 2021 Apr 1;273(4):792-799. doi: 10.1097/SLA.0000000000003358.
9
Effect of Microvascular Invasion Risk on Early Recurrence of Hepatocellular Carcinoma After Surgery and Radiofrequency Ablation.微血管侵犯风险对手术和射频消融后肝细胞癌早期复发的影响。
Ann Surg. 2021 Mar 1;273(3):564-571. doi: 10.1097/SLA.0000000000003268.
10
Optimal postoperative adjuvant treatment strategy for HBV-related hepatocellular carcinoma with microvascular invasion: a propensity score analysis.伴有微血管侵犯的HBV相关肝细胞癌的最佳术后辅助治疗策略:一项倾向评分分析
Onco Targets Ther. 2019 Feb 15;12:1237-1247. doi: 10.2147/OTT.S179247. eCollection 2019.